ALKEM - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.8
| Stock Code | ALKEM | Market Cap | 67,446 Cr. | Current Price | 5,642 ₹ | High / Low | 5,934 ₹ |
| Stock P/E | 30.2 | Book Value | 1,143 ₹ | Dividend Yield | 0.80 % | ROCE | 19.5 % |
| ROE | 19.9 % | Face Value | 2.00 ₹ | DMA 50 | 5,656 ₹ | DMA 200 | 5,438 ₹ |
| Chg in FII Hold | 0.50 % | Chg in DII Hold | -0.39 % | PAT Qtr | 724 Cr. | PAT Prev Qtr | 610 Cr. |
| RSI | 48.2 | MACD | -6.34 | Volume | 79,440 | Avg Vol 1Wk | 1,06,635 |
| Low price | 4,492 ₹ | High price | 5,934 ₹ | PEG Ratio | 2.17 | Debt to equity | 0.06 |
| 52w Index | 79.8 % | Qtr Profit Var | 12.8 % | EPS | 204 ₹ | Industry PE | 29.1 |
📊 Analysis: ALKEM is trading at ₹5,642, slightly below its 50 DMA (₹5,656) but above its 200 DMA (₹5,438), reflecting mixed momentum. RSI at 48.2 indicates neutral positioning, while MACD (-6.34) shows mild bearish crossover. Intraday volume (79,440) is lower than the weekly average (1,06,635), suggesting reduced participation. Fundamentals remain strong with ROCE (19.5%), ROE (19.9%), and minimal debt-to-equity (0.06). Valuation is close to industry average (P/E 30.2 vs 29.1), supported by quarterly PAT growth (+12.8%). Short-term technicals show caution, but strong fundamentals make it moderately favorable for intraday trading.
💡 Optimal Buy Price: ₹5,620–5,630 if price consolidates near support.
🎯 Profit-Taking Levels: ₹5,690–5,710 (near 50 DMA resistance).
🛡️ Stop-Loss: ₹5,600 to protect against downside risk.
⏱️ Exit Strategy (if already holding): Exit if price fails to sustain above ₹5,690 with strong volume. Momentum indicators suggest limited upside, so profit booking should be considered near resistance levels to avoid reversal risk.
Positive
- Strong ROCE (19.5%) and ROE (19.9%) highlight efficient capital use.
- EPS of ₹204 reflects strong earnings power.
- Debt-to-equity ratio of 0.06 indicates a virtually debt-free balance sheet.
- Quarterly PAT growth from ₹610 Cr. to ₹724 Cr. (+12.8%).
- FII holding increased by 0.50%, showing foreign investor confidence.
Limitation
- Trading below 50 DMA indicates short-term weakness.
- MACD negative crossover suggests bearish momentum.
- Intraday volume lower than average, limiting momentum trades.
- DII holding decreased by 0.39%, showing reduced domestic support.
Company Negative News
- No major negative news reported, but short-term technical weakness persists.
Company Positive News
- Quarterly profit growth supports earnings momentum.
- Strong fundamentals with high ROCE, ROE, and EPS.
Industry
- Industry P/E at 29.1 indicates sector is moderately valued.
- Pharmaceutical sector benefiting from healthcare demand and expansion opportunities.
Conclusion
⚖️ ALKEM shows strong fundamentals but weak short-term technical momentum. It is a moderate candidate for intraday trading with entry near ₹5,620–5,630 and profit-taking around ₹5,690–5,710. Traders should closely monitor volume and momentum indicators before committing to positions.